New weight-loss medication could be a medical marvel or the next health crisis

While the benefits are undeniable, the rapid adoption of GLP-1 agonists raises concerns about potential long-term consequences, dependency, and our relationship with food and health.

Nicole Saphier, M.D., is a board certified radiologist with advanced fellowship training in breast imaging, Fox News medical contributor and bestselling author. Her new book is "Love, Mom." She is also the bestselling author of "Make America Healthy Again" and "Panic Attack: Playing Politics with Science in the Fight Against COVID-19." Follow her on X, formerly known as Twitter @NBSaphierMD and Instagram @nicolesaphier_md.

GLP-1 agonists work by mimicking the action of the hormone glucagon-like peptide-1, which increases insulin secretion, decreases glucagon release and slows gastric emptying. This results in reduced appetite, increased satiety, and improved glycemic control, making these medications incredibly effective for weight loss and managing diabetes.